RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 100 filers reported holding RAPT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $551 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $35,171,000 | 45.66% |
| KPCB XV Associates, LLC | 1,297,063 | $28,522,000 | 36.91% |
| Ponoi II Management, LLC | 145,401 | $3,197,000 | 7.10% |
| Column Group LLC | 1,402,008 | $30,830,000 | 5.72% |
| Euclidean Capital LLC | 432,900 | $9,519,000 | 5.53% |
| AJU IB Investment Co., Ltd. | 99,503 | $2,188,000 | 3.38% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,088,321 | $23,932,000 | 2.49% |
| Velan Capital Investment Management LP | 110,000 | $2,419,000 | 2.24% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $9,755,000 | 1.46% |
| Perceptive Advisors | 2,799,962 | $61,571,000 | 1.23% |